Skip to main content

Advertisement

Figure 1 | BMC Infectious Diseases

Figure 1

From: Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices

Figure 1

Model-projected HIV prevalence and incidence trends over time and data used to fit model*. a: HIV prevalence trends among general population males and females in 2002 and 2005. b: HIV prevalence trends among the general population and among female sex workers in 2008. c: HIV incidence trends among general population males and females. *The points with error bars for males and females in 2002 and 2005 represent the mean and 95% confidence intervals derived from data [12, 26]. The dotted line represents the model-projected female HIV prevalence while the solid line represents the model-projected male HIV prevalence. The shaded areas represent the range of prevalence estimates spanned by all model fits.

Back to article page